World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Molecular Biology 107 407 372 233 208 311 54643
Biology and Biochemistry 118 695 616 440 380 431 60113

C. Frank Bennett publications per year

The chart shows the history of publications by C. Frank Bennett between 1991 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. C. Frank Bennett published across 36 years, from 1991 to 2026, averaging 13.8 papers a year. Output peaked at 33 publications in 1999. 19 of the 497 publications appeared in the last two years.

No. of publications
10 20 30
Bar chart. Horizontal axis: year, 1991 to 2026. Vertical axis: number of publications, 0 to 33. Peak 33 publications in 1999. 1991: 4 publications 1992: 1 publication 1993: 11 publications 1994: 11 publications 1995: 5 publications 1996: 7 publications 1997: 14 publications 1998: 22 publications 1999: 33 publications 2000: 20 publications 2001: 27 publications 2002: 33 publications 2003: 24 publications 2004: 19 publications 2005: 8 publications 2006: 10 publications 2007: 5 publications 2008: 7 publications 2009: 5 publications 2010: 10 publications 2011: 13 publications 2012: 17 publications 2013: 16 publications 2014: 13 publications 2015: 16 publications 2016: 23 publications 2017: 21 publications 2018: 16 publications 2019: 15 publications 2020: 11 publications 2021: 14 publications 2022: 3 publications 2023: 17 publications 2024: 7 publications 2025: 10 publications 2026: 9 publications
1991 2026

497 publications in total across all disciplines

View publications per year as a table
C. Frank Bennett: publications per year, 1991 to 2026
Year Publications
1991 4
1992 1
1993 11
1994 11
1995 5
1996 7
1997 14
1998 22
1999 33
2000 20
2001 27
2002 33
2003 24
2004 19
2005 8
2006 10
2007 5
2008 7
2009 5
2010 10
2011 13
2012 17
2013 16
2014 13
2015 16
2016 23
2017 21
2018 16
2019 15
2020 11
2021 14
2022 3
2023 17
2024 7
2025 10
2026 9
Total 497
Download as CSV

C. Frank Bennett publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where C. Frank Bennett sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 53 bars. Horizontal axis: publications, 47–56 to 564+. Vertical axis: number of scientists, 0 to 177. Most scientists, 177, have 117–126 publications. The last bar groups every scientist with 564 publications or more. The highlighted bar, 307–316 publications, is where this scientist sits. 47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47–56 publications 564+

This scientist: 311 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

View publications distribution as a table
Number of Molecular Biology scientists by publication count, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
Publications Scientists This scientist
47–56 7
57–66 17
67–76 65
77–86 90
87–96 125
97–106 131
107–116 162
117–126 177
127–136 158
137–146 158
147–156 146
157–166 159
167–176 131
177–186 110
187–196 112
197–206 100
207–216 89
217–226 98
227–236 74
237–246 72
247–256 63
257–266 53
267–276 54
277–286 49
287–296 52
297–306 43
307–316 46 311
317–326 41
327–336 42
337–346 31
347–356 28
357–366 29
367–376 26
377–386 24
387–396 24
397–406 14
407–416 13
417–426 20
427–436 12
437–446 20
447–456 11
457–466 10
467–476 14
477–486 14
487–496 10
497–506 13
507–516 13
517–526 2
527–536 4
537–546 6
547–556 8
557–563 6
564+ 100
Download as CSV

C. Frank Bennett D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where C. Frank Bennett sits on this spectrum.

No. of scientists
25 50 75 100 125
Bar chart with 54 bars. Horizontal axis: D-Index, 40–41 to 145+. Vertical axis: number of scientists, 0 to 131. Most scientists, 131, have 64–65 D-Index. The last bar groups every scientist with 145 D-Index or more. The highlighted bar, 106–107 D-Index, is where this scientist sits. 40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40–41 D-Index 145+

This scientist: 107 D-Index — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

View D-Index distribution as a table
Number of Molecular Biology scientists by D-index, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
D-Index Scientists This scientist
40–41 36
42–43 101
44–45 115
46–47 121
48–49 118
50–51 130
52–53 106
54–55 116
56–57 113
58–59 129
60–61 120
62–63 105
64–65 131
66–67 95
68–69 97
70–71 106
72–73 83
74–75 89
76–77 77
78–79 70
80–81 73
82–83 60
84–85 48
86–87 45
88–89 50
90–91 31
92–93 51
94–95 43
96–97 38
98–99 39
100–101 41
102–103 29
104–105 33
106–107 35 107
108–109 20
110–111 38
112–113 19
114–115 28
116–117 13
118–119 23
120–121 16
122–123 15
124–125 11
126–127 21
128–129 7
130–131 13
132–133 14
134–135 17
136–137 9
138–139 8
140–141 16
142–143 7
144 7
145+ 100
Download as CSV

Research.com Recognitions

  • 2019 - Breakthrough Prize in Life Sciences for the development of an effective antisense oligonucleotide therapy for children with the neurodegenerative disease spinal muscular atrophy.

Overview

C. Frank Bennett is affiliated with Ionis Pharmaceuticals in the United States and has a significant body of work primarily in the fields of Biochemistry, Genetics and Molecular Biology, as well as Medicine. Their research encompasses key subfields including Molecular Biology, Genetics, Neurology, Cellular and Molecular Neuroscience, and Surgery.

The scientist's main topics of study focus on Neurogenetic and Muscular Disorders Research, RNA Research and Splicing, RNA modifications and cancer, Amyotrophic Lateral Sclerosis (ALS) Research, Genetic Neurodegenerative Diseases, Muscle Physiology and Disorders, and RNA regulation and disease.

Frank Bennett has contributed to several prominent research publications with papers appearing in high-impact journals. Notable recent papers include:

  • Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS, 2020, New England Journal of Medicine
  • Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial, 2023, Nature Medicine
  • Mechanism of STMN2 cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies, 2023, Science
  • Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial, 2021, Nature Medicine
  • Cholesterol-functionalized DNA/RNA heteroduplexes cross the blood-brain barrier and knock down genes in the rodent CNS, 2021, Nature Biotechnology

Frequent co-authors in Bennett's work include Frank Rigo, Roger Lane, Karen Ling, Don W. Cleveland, and Holly Kordasiewicz. These collaborations indicate ongoing partnerships in advancing research related to antisense oligonucleotides and neurodegenerative diseases.

The scientist has published frequently in several notable venues, including bioRxiv (Cold Spring Harbor Laboratory), Nature Medicine, Human Molecular Genetics, Nature Communications, and Nucleic Acids Research. The diversity of these platforms reflects a broad impact across multiple areas within molecular genetics and neurological research.

Best Publications

  • miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting.

    Christine Esau;Scott Davis;Susan F. Murray;Xing Xian Yu

  • The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation.

    Vidisha Tripathi;Jonathan D. Ellis;Zhen Shen;David Y. Song

  • Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy

    Richard S. Finkel;Eugenio Mercuri;Basil T. Darras;Anne M. Connolly

  • RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform

    C Frank Bennett;Eric E Swayze

  • Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43

    Magdalini Polymenidou;Clotilde Lagier-Tourenne;Kasey R. Hutt;Stephanie C. Huelga

  • MicroRNA-143 regulates adipocyte differentiation.

    Christine Esau;Xiaolin Kang;Eigen Peralta;Elaine Hanson

  • Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy

    Eugenio Mercuri;Basil T. Darras;Claudia A. Chiriboga;John W. Day

  • Antisense oligonucleotide modulation of multidrug resistance-associated protein

    Edgardo Baracchini;C. Frank Bennett;Nicholas M. Dean

  • RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention

    Christopher J. Donnelly;Ping-Wu Zhang;Jacqueline T. Pham;Aaron R. Haeusler

  • Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study

    Richard S Finkel;Claudia A Chiriboga;Jiri Vajsar;John W Day

  • Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides.

    Richard S. Geary;Daniel Norris;Rosie Yu;C. Frank Bennett

  • Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis.

    Holly B. Kordasiewicz;Lisa M. Stanek;Edward V. Wancewicz;Curt Mazur

  • Efficient Reduction of Target RNAs by Small Interfering RNA and RNase H-dependent Antisense Agents: A COMPARATIVE ANALYSIS *

    Timothy A. Vickers;Seongjoon Koo;C. Frank Bennett;Stanley T. Crooke

  • Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs

    Clotilde Lagier-Tourenne;Magdalini Polymenidou;Kasey R. Hutt;Anthony Q. Vu

  • Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion

    Dhruv Sareen;Jacqueline G. O’Rourke;Pratap Meera;A. K. M. G. Muhammad

  • Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model

    Yimin Hua;Kentaro Sahashi;Frank Rigo;Gene Hung

  • RNA-Targeted Therapeutics.

    Stanley T. Crooke;Joseph L. Witztum;C. Frank Bennett;Brenda F. Baker

  • Regulating Gene Expression through RNA Nuclear Retention

    Kannanganattu V. Prasanth;Supriya G. Prasanth;Zhenyu Xuan;Stephen Hearn

  • Antisense Masking of an hnRNP A1/A2 Intronic Splicing Silencer Corrects SMN2 Splicing in Transgenic Mice

    Yimin Hua;Timothy A. Vickers;Hazeem L. Okunola;C. Frank Bennett

  • Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model

    Yimin Hua;Kentaro Sahashi;Gene Hung;Frank Rigo

Frequent Co-Authors

Frank Rigo
Frank Rigo Ionis Pharmaceuticals (United States)
Nicholas M. Dean
Nicholas M. Dean Ionis Pharmaceuticals (United States)
Eric E. Swayze
Eric E. Swayze Ionis Pharmaceuticals (United States)
Adrian R. Krainer
Adrian R. Krainer Cold Spring Harbor Laboratory
Don W. Cleveland
Don W. Cleveland University of California, San Diego
David J. Ecker
David J. Ecker Ionis Pharmaceuticals (United States)
Brett P. Monia
Brett P. Monia Ionis Pharmaceuticals (United States)
David L. Spector
David L. Spector Cold Spring Harbor Laboratory
Punit P. Seth
Punit P. Seth Ionis Pharmaceuticals (United States)
Muthiah Manoharan
Muthiah Manoharan Alnylam Pharmaceuticals (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing C. Frank Bennett

Trending Scientists

Recently Published Articles